Skip to main content
SpringerLink
Log in

Psychotropic Medications and Crime

The Seasoning of the Prozac Defense

  • Chapter
Handbook of Drug Interactions

Part of the book series: Forensic Science and Medicine ((FSM))

  • 474 Accesses

Abstract

Psychiatrists are asked to assess criminal responsibility for prospective insanity and diminished capacity defenses, and as part of presentencing efforts in capital cases. The examinees may present with a history of having been treated with psychotropics at the time of the offense.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grinfeld M and Welner M. Pill poisoned? The seasoning of medication defenses. The Forensic Echo 2(3):4–10 (1998).

    Google Scholar 

  2. Teicher MH, Glod C, and Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147(2):207–210 (1990).

    PubMed  CAS  Google Scholar 

  3. Grinfeld M and Welner M. Pill poisoned? The seasoning of medication defenses. The Forensic Echo 2(3):3–6 (1998).

    Google Scholar 

  4. Locy T and Pasternak D. Can drugs spark acts of violence? U.S. News and World Report 128(9):44 (2000).

    Google Scholar 

  5. Walsh MT and Dinan TG. Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatr Scand 104(2):84–91(2001).

    Article  PubMed  CAS  Google Scholar 

  6. Buck OD. Sertraline for reduction of violent behavior. Am J Psychiatry 152(6):953 (1995).

    PubMed  CAS  Google Scholar 

  7. Frankenfield DL, Baker SP, Lange WR, Caplan YH, and Smialek JE. Fluoxetine and violent death in Maryland. Forensic Sci Int 64(2–3):107–117 (1994).

    Article  PubMed  CAS  Google Scholar 

  8. Heiligenstein JH, Beasley CM Jr, and Potvin JH. Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 8(4):277–280 (1993).

    Article  PubMed  CAS  Google Scholar 

  9. Fava M, Rosenbaum JF, McCarthy M, Pava J, Steingard R, and Bless E. Anger attacks in depressed outpatients and their response to fluoxetine. Psychopharmacol Bull 27(3): 275–279 (1991).

    PubMed  CAS  Google Scholar 

  10. Fava M, Rosenbaum JF, Pava JA, McCarthy MK, Steingard RJ, and Bouffides E. Anger attacks in unipolar depression, Part 1: clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150(8):1158–1163 (1993).

    PubMed  CAS  Google Scholar 

  11. Fava M, Alpert J, Nierenberg AA, Ghaemi N, O’Sullivan R, Tedlow J, et al. Fluoxetine treatment of anger attacks: a replication study. Ann Clin Psychiatry 8(1):7–10 (1996).

    Article  PubMed  CAS  Google Scholar 

  12. Fava M, Nierenberg AA, Quitkin F, et al. A preliminary study of the efficacy of sertraline and imipramine on anger attacks in depression. NCDEU annual meeting (1995).

    Google Scholar 

  13. Rubey RN, Johnson MR, Emmanuel N, and Lydiard RB. Fluoxetine in the treatment of anger: an open clinical trial. J Clin Psychiatry 57:398–401 (1996).

    PubMed  CAS  Google Scholar 

  14. Coccaro EF and Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psych 103:1081–1088 (1997).

    Article  Google Scholar 

  15. Doctors release man who tried to kill his wife. The Capital. February 24, 2001.

    Google Scholar 

  16. Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucler J, et al. Antidepressantassociated mania: a controlled comparison with spontaneous mania. Am J of Psychiatry 151(11):1642–1645 (1994).

    CAS  Google Scholar 

  17. Physicians Desk Reference. Montvale, NJ: Medical Economics, 2001.

    Google Scholar 

  18. Tomb DA. Psychiatry for the house officer. Baltimore: Williams & Wilkins, 1981.

    Google Scholar 

  19. Radomski JW, Dursun SM, Reveley MA, and Kutcher SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 55(3):218–224 (2000).

    Article  PubMed  CAS  Google Scholar 

  20. Bhanji NH. Serotonin syndrome following low-dose sertraline. Can J of Psychiatry 45(10): 936–937 (2000).

    CAS  Google Scholar 

  21. State of Connecticut v. Christopher DeAngelo. 2000 Conn. Super. LEXIS 1557.

    Google Scholar 

  22. Gorman JM. The essential guide to psychiatric drugs. New York: St. Martin’s Press, 1990: 143–144.

    Google Scholar 

  23. Ingram IM and Timbury GC. Side effects of Librium. Lancet 2:766 (1960).

    Article  Google Scholar 

  24. Deitch J and Jennings R. Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psych 49(5):184–188 (1988).

    Google Scholar 

  25. Gardner RL and Cowdry RW. Alprazolam-induced dyscontrol in borderline personality disorder. Am J Psychiatry 142:98–100 (1985).

    PubMed  CAS  Google Scholar 

  26. Bond AJ, Curran HV, Bruce MS, O’Sullivan G, and Shine P. Behavioral aggression in panic disorder after 8 weeks’ treatment with alprazolam. J Affective Disorder 35(3):117–123 (1995).

    Article  CAS  Google Scholar 

  27. Welner M. Drug-facilitated sexual assault. New York: Academic Press, 2001.

    Google Scholar 

  28. Daderman AM, Fredriksson B, and Kristiansson M. Violent behavior, impulsive decisionmaking, and anterograde amnesia while intoxicated with flunitrazepam and alcohol or other drugs: a case study in forensic psychiatric patients. J Am Acad Psychiatry Law 30(2):238–251 (2002).

    PubMed  Google Scholar 

  29. American Psychiatric Association. Benzodiazepine: dependence, toxicity, and abuse. Washington, DC: American Psychiatric Association, 1990:44.

    Google Scholar 

  30. Kaplan HI, Sadock BJ, and Grebb JA. Synopsis of psychiatry: behavior sciences clinical psychiatry. Baltimore: Williams & Wilkins, 1994:911.

    Google Scholar 

  31. American Psychiatric Association. Benzodiazepine: dependence, toxicity, and abuse. Washington, DC: American Psychiatric Association, 1990:15–19, 49–57.

    Google Scholar 

  32. Boswell v. State, 610 So. 2d 670.

    Google Scholar 

  33. DSM-III-R. Washington, DC: American Psychiatric Association, 1987:87.

    Google Scholar 

  34. DSM-IV Washington, DC: American Psychiatric Association, 1994:77.

    Google Scholar 

  35. Maletzky BM. The diagnosis of pathological intoxication. J Stud Alcohol 37(9):1215–1228 (1976).

    PubMed  CAS  Google Scholar 

  36. Defense of drunkenness in English criminal law. 49 LQ Rev 528, 533 (1933).

    Google Scholar 

  37. 30 ALR 761–762 (1924).

    Google Scholar 

  38. Commonwealth v. Walker, 283 Pa 468, 129 A 453 (1925).

    Google Scholar 

  39. State v. Hall, 214 NW2d 205 (1974, Iowa).

    Google Scholar 

  40. Tackett v. Commonwealth, 205 Ky 490, 266 SW 26 (1924).

    Google Scholar 

  41. People v. Gerrior, 155 Ill App 3d 949 (1987, 2d Dist).

    Google Scholar 

  42. Burchfield v. State, 219 Ga App 40 (1995).

    Google Scholar 

  43. Commonwealth v. McAlister, 313 NE2d 113 (1974, Mass).

    Google Scholar 

  44. Jones v. State, 648 P2d 1251, 103 S Ct 799 (1982, Okla Crim).

    Google Scholar 

  45. Teeters v. Commonwealth, 310 Ky 546, 221 SW 2d 85 (1949).

    Google Scholar 

  46. State v. Rippy, 104 NC752, 10 SE 259 (1889).

    Google Scholar 

  47. Aliifff v. State, 955 S.W.2d 891.

    Google Scholar 

  48. People v. Baker, 42 Cal 2d 550 (1954).

    Google Scholar 

  49. State v. Gardner, 230 Wis. 2d 32, 601 N.W. 2d 670.

    Google Scholar 

  50. Arizona v. McKeon, 2002 Ariz. App. LEXIS 8.

    Google Scholar 

  51. Bennett v. State, 161 Ark 496 (1923).

    Google Scholar 

  52. Simon RI and Sadoff RL. Psychiatric malpractice: cases and comments for clinicians. Washington, DC: American Psychiatric Press, 1992:101.

    Google Scholar 

  53. Kaplan H and Sadock B. Pocket handbook of psychiatric drug treatment. Baltimore: Williams & Wilkins, 1993.

    Google Scholar 

  54. Weiner M. Medication defenses: myths and realities. american psychiatric association annual meeting, May 22, 2002, Philadelphia.

    Google Scholar 

  55. Miller v. Florida, 2001 Fla. App. LEXIS 14475.

    Google Scholar 

  56. Michigan v. Wilkins, 184 Mich. App. 443.

    Google Scholar 

  57. Kaplan HI, Sadock BJ, and Grebb JA. Synopsis of psychiatry: behavior sciences clinical psychiatry. Baltimore: Williams & Wilkins, 1994.

    Google Scholar 

  58. Aubry J M, Simon AE, and Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry 61(9):649–655 (2000).

    Article  PubMed  CAS  Google Scholar 

  59. Pleak RR, Birmaher B, Gavrilescu A, Abichandani C, and Williams DT. Mania and neuropsychiatric excitation following carbamazepine. J American Academy Child Adolesc Psychiatry 27:500–503 (1988).

    Article  CAS  Google Scholar 

  60. Kaplan HI, Sadock BJ, and Grebb JA. Synopsis of psychiatry: behavior sciences clinical psychiatry. Baltimore: Williams & Wilkins, 1994.

    Google Scholar 

  61. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, and Strakowski SM. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 37(4):229–240 (1996).

    Article  PubMed  CAS  Google Scholar 

  62. Chengappa KN, Vasile J, Levine J, Ulrich R, Baker R, and Gopalani A. Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophr Res 53 (1–2):1–6 (2002).

    Article  PubMed  CAS  Google Scholar 

  63. Sheard MH. Effect of lithium on human aggression. Nature 230:113–114 (1971).

    Article  PubMed  CAS  Google Scholar 

  64. Meltzer HY. Treatment of suicidality in schizophrenia. Ann NY Acad Sci 932:44–58 (2001).

    Article  PubMed  CAS  Google Scholar 

  65. Physicians Desk Reference. Montvale, NJ: Medical Economics, 2001.

    Google Scholar 

  66. Wysowski DK, Pitts M, and Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 45(4):515–519 (2001).

    Article  PubMed  CAS  Google Scholar 

  67. Bard M and Welner M. Bad acne: guilty defendant may bring med mal. The Forensic Echo 2(3):23–24 (1998).

    Google Scholar 

  68. Jacobs DG, Deutsch NL, and Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 45(5):S168-S175 (2001).

    Article  Google Scholar 

  69. Isotretinoin, no other drugs found in Florida teen pilot’s body. Dermatology Times. February 2002.

    Google Scholar 

  70. van Riemsdijk MM, van der Klauw MM, van Heest JA, Reedeker FR, Ligthelm RJ, Herings RM, and Stricker BH. Neuropsychiatric effects of antimalarials. Eur J Clin Pharmac 52: 1–6 (1997).

    Article  Google Scholar 

  71. Rouveix B, Bricaire F, Michon C, Franssen G, Lebras J, and Bernard J. Mefloquine and an acute brain syndrome. Ann Internal Med 110:577–578 (1989).

    Article  CAS  Google Scholar 

  72. Speich R and Haller A. Central anticholinergic syndrome with the antimalarial mefloquine. N Engl J Med 331:57–58 (1994).

    Article  PubMed  CAS  Google Scholar 

  73. Stuiver PC, Lightelm RJ, and Gould TJLM. Acute psychosis after mefloquine. Lancet 2: 282 (1989).

    Article  PubMed  CAS  Google Scholar 

  74. Hennequin C, Bouree P, Bazin N, Bisaro F, and Feline A. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med 154(20):2360–2362 (1994).

    Article  PubMed  CAS  Google Scholar 

  75. US v. Mezvinsky, 206 F. Supp. 2d 661 (E.D. Pa 2002).

    Google Scholar 

  76. Benjamin M and Olmstead R. Army had 1996 Lariam warning. United Press Int’l. Aug 22, 2002.

    Google Scholar 

  77. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277(4):333–340 (1997).

    Article  PubMed  CAS  Google Scholar 

  78. Metzner JL. Class action litigation in correctional psychiatry. J Am Acad Psychiatry Law 30(1):19–29 (2002).

    PubMed  Google Scholar 

  79. Perloms v. United States, (1915, CA4 SC) 228 F 408.

    Google Scholar 

  80. Rosenheck R, Chang S, Choe Y, Cramer J, Xu W, Thomas J, et al. Medication continuation and compliance: A comparison of patients treated with clozapine and haloperidol. J Clin Psych 61(5):382–386 (2000).

    Article  CAS  Google Scholar 

  81. Bosker G and Albrich JM. Emergency detection of adverse drug reactions in the elderly. Resident and Staff Physician (September, 1989).

    Google Scholar 

  82. Jansen PL. Liver disease in the elderly. Best Pract Res Clin Gastroenterol 16(1):149–158 (2002).

    Article  PubMed  Google Scholar 

  83. Thompson D and Pollock B. Psychotropic metabolism: gender-related issues. Psychiatric Times 47–49 (January 2001).

    Google Scholar 

  84. Maletzky BM. The episodic dyscontrol syndrome. Dis Nerv Syst 34:178–185 (1973).

    PubMed  CAS  Google Scholar 

  85. Pounder DJ. The nightmare of postmortem drug changes. In: Wecht CH, ed. Legal Medicine. Salem: Buttersworth, 1993:163–191.

    Google Scholar 

  86. Koh A and Pizzo PA. Empirical oral anitbiotic therapy for low risk febrile cancer patients with neutropenia. Cancer Invest 20(3):420–433 (2002).

    Article  PubMed  CAS  Google Scholar 

  87. Tamminga WJ, Werner J, Oostehuis B, Wieling J, Wilfert B, de Liej LFMH, et al. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Euro J Clin Pharmacol 55(3):177–184 (1999).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Michael Welner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harris County Medical Examiner Office, Houston, TX, USA

    Ashraf Mozayani PharmD, PhD

  2. University of Miami School of Medicine, Miami, FL, USA

    Lionel P. Raymon PharmD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Welner, M. (2004). Psychotropic Medications and Crime. In: Mozayani, A., Raymon, L.P. (eds) Handbook of Drug Interactions. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-654-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-654-6_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-424-1

  • Online ISBN: 978-1-59259-654-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation